JP2011517458A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517458A5
JP2011517458A5 JP2011503082A JP2011503082A JP2011517458A5 JP 2011517458 A5 JP2011517458 A5 JP 2011517458A5 JP 2011503082 A JP2011503082 A JP 2011503082A JP 2011503082 A JP2011503082 A JP 2011503082A JP 2011517458 A5 JP2011517458 A5 JP 2011517458A5
Authority
JP
Japan
Prior art keywords
pyrimidin
benzamide
pyrazolo
hydroxypropan
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011503082A
Other languages
English (en)
Japanese (ja)
Other versions
JP5432982B2 (ja
JP2011517458A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/038840 external-priority patent/WO2009123986A1/en
Publication of JP2011517458A publication Critical patent/JP2011517458A/ja
Publication of JP2011517458A5 publication Critical patent/JP2011517458A5/ja
Application granted granted Critical
Publication of JP5432982B2 publication Critical patent/JP5432982B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011503082A 2008-03-31 2009-03-30 アポトーシスシグナル調節キナーゼ1阻害剤 Expired - Fee Related JP5432982B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4116608P 2008-03-31 2008-03-31
US61/041,166 2008-03-31
PCT/US2009/038840 WO2009123986A1 (en) 2008-03-31 2009-03-30 Apoptosis signal-regulating kinase 1 inhibitors

Publications (3)

Publication Number Publication Date
JP2011517458A JP2011517458A (ja) 2011-06-09
JP2011517458A5 true JP2011517458A5 (enExample) 2012-05-24
JP5432982B2 JP5432982B2 (ja) 2014-03-05

Family

ID=40750935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011503082A Expired - Fee Related JP5432982B2 (ja) 2008-03-31 2009-03-30 アポトーシスシグナル調節キナーゼ1阻害剤

Country Status (4)

Country Link
US (2) US8461163B2 (enExample)
EP (1) EP2271646A1 (enExample)
JP (1) JP5432982B2 (enExample)
WO (1) WO2009123986A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2416660B1 (en) * 2009-04-07 2014-07-02 Infinity Pharmaceuticals, Inc. Inhibitors of fatty acid amide hydrolase
TWI491606B (zh) 2009-07-13 2015-07-11 Gilead Sciences Inc 調節細胞凋亡信號之激酶的抑制劑
WO2011041293A1 (en) * 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
WO2011097079A1 (en) * 2010-02-03 2011-08-11 Takeda Pharmaceutical Company Limited Apoptosis signal-regulating kinase 1 inhibitors
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
AU2011272782B2 (en) 2010-07-02 2014-11-27 Gilead Sciences, Inc. Apoptosis signal-regulating kinase inhibitors
WO2012011548A1 (ja) * 2010-07-23 2012-01-26 国立大学法人 東京大学 含窒素複素環誘導体
JP5927201B2 (ja) * 2010-12-16 2016-06-01 カルチャン リミテッド Ask1阻害ピロロピリミジン誘導体
JP6027610B2 (ja) 2011-07-19 2016-11-16 インフィニティー ファーマシューティカルズ, インコーポレイテッド 複素環式化合物及びその使用
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP6122868B2 (ja) * 2011-12-22 2017-04-26 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス剤としてのピラゾロ[1,5−a]ピリミジン
UY34573A (es) 2012-01-27 2013-06-28 Gilead Sciences Inc Inhibidor de la quinasa que regula la señal de la apoptosis
DK2947084T3 (da) * 2013-01-18 2020-11-02 Guangzhou Maxinovel Pharmaceuticals Co Fem- og seks-ledet heterocyklisk forbindelse og forberedelsesmetode, farmaceutisk sammensætning og anvendelse deraf
CN105636592A (zh) * 2013-07-11 2016-06-01 伊万斯彻有限公司 形成前药的化合物
GB201410817D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
TW201618781A (zh) 2014-08-13 2016-06-01 吉李德科學股份有限公司 治療肺高血壓之方法
SG11201701723XA (en) 2014-09-24 2017-04-27 Gilead Sciences Inc Methods of treating liver disease
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
WO2016106384A1 (en) 2014-12-23 2016-06-30 Gilead Sciences, Inc. Processes for preparing ask1 inhibitors
CN105906621A (zh) * 2015-04-06 2016-08-31 四川百利药业有限责任公司 用作fgfr抑制剂的乙醇类化合物
ES2928164T3 (es) 2015-10-19 2022-11-15 Incyte Corp Compuestos heterocíclicos como inmunomoduladores
MD3377488T2 (ro) 2015-11-19 2023-02-28 Incyte Corp Compuși heterociclici ca imunomodulatori
MA44075A (fr) 2015-12-17 2021-05-19 Incyte Corp Dérivés de n-phényl-pyridine-2-carboxamide et leur utilisation en tant que modulateurs des interactions protéine/protéine pd-1/pd-l1
MY199705A (en) 2015-12-22 2023-11-20 Incyte Corp Heterocyclic compounds as immunomodulators
WO2017192961A1 (en) 2016-05-06 2017-11-09 Incyte Corporation Heterocyclic compounds as immunomodulators
WO2017205464A1 (en) 2016-05-26 2017-11-30 Incyte Corporation Heterocyclic compounds as immunomodulators
KR102685249B1 (ko) 2016-06-20 2024-07-17 인사이트 코포레이션 면역조절제로서의 복소환식 화합물
MA45669A (fr) 2016-07-14 2019-05-22 Incyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
WO2018044783A1 (en) 2016-08-29 2018-03-08 Incyte Corporation Heterocyclic compounds as immunomodulators
JOP20190144A1 (ar) * 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
EP3558973B1 (en) 2016-12-22 2021-09-15 Incyte Corporation Pyridine derivatives as immunomodulators
EP3558989B1 (en) 2016-12-22 2021-04-14 Incyte Corporation Triazolo[1,5-a]pyridine derivatives as immunomodulators
WO2018119224A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
PE20191532A1 (es) 2016-12-22 2019-10-23 Incyte Corp Compuestos heterociclicos como inmunomoduladores
CA3047991A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Bicyclic heteroaromatic compounds as immunomodulators
HU231057B1 (hu) * 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
HU231058B1 (hu) * 2017-03-13 2020-04-28 Richter Gedeon Nyrt. Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
ES2971098T3 (es) 2017-05-12 2024-06-03 Enanta Pharm Inc Inhibidores de la quinasa 1 que regula la señal de apoptosis y métodos de uso de los mismos
WO2018218051A1 (en) 2017-05-25 2018-11-29 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US10253018B2 (en) 2017-05-25 2019-04-09 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US10246439B2 (en) 2017-05-25 2019-04-02 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
GB201711234D0 (en) 2017-07-12 2017-08-23 Galapagos Nv Pyrrolopyrimidine and pyrrolopyridine derivatives
US10597382B2 (en) 2017-08-28 2020-03-24 Enanta Pharmaceuticals, Inc. Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
RS64055B1 (sr) 2018-03-30 2023-04-28 Incyte Corp Heterociklična jedinjenja kao imunomodulatori
US10683289B2 (en) 2018-05-02 2020-06-16 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
EP3787621B1 (en) * 2018-05-02 2024-12-18 Enanta Pharmaceuticals, Inc. Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
MD3790877T2 (ro) 2018-05-11 2023-08-31 Incyte Corp Derivați de tetrahidro-imidazo[4,5-c]piridină în calitate de imunomodulatori PD-L1
WO2020036949A1 (en) * 2018-08-14 2020-02-20 Biogen Ma Inc. Ask1 inhibiting agents
US10968199B2 (en) 2018-08-22 2021-04-06 Enanta Pharmaceuticals, Inc. Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
US11345699B2 (en) 2018-11-19 2022-05-31 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
WO2020198214A1 (en) 2019-03-25 2020-10-01 Enanta Pharmaceuticals, Inc. Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
JP7665593B2 (ja) 2019-08-09 2025-04-21 インサイト・コーポレイション Pd-1/pd-l1阻害剤の塩
AR120109A1 (es) 2019-09-30 2022-02-02 Incyte Corp Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores
PE20230407A1 (es) 2019-11-11 2023-03-07 Incyte Corp Sales y formas cristalinas de un inhibidor de pd-1/pd-l1
CA3187362A1 (en) 2020-07-27 2022-02-03 John Thomas Feutrill Compounds
WO2022020889A1 (en) * 2020-07-27 2022-02-03 Esfam Biotech Pty Ltd Method of treatment of cytomegalovirus
WO2022020891A1 (en) * 2020-07-27 2022-02-03 Esfam Biotech Pty Ltd Methods of prophylaxis and treatment of corona virus
WO2022099018A1 (en) 2020-11-06 2022-05-12 Incyte Corporation Process of preparing a pd-1/pd-l1 inhibitor
TW202233616A (zh) 2020-11-06 2022-09-01 美商英塞特公司 用於製備pd-1/pd-l1抑制劑以及其鹽及結晶形式之方法
WO2022099075A1 (en) 2020-11-06 2022-05-12 Incyte Corporation Crystalline form of a pd-1/pd-l1 inhibitor
AU2022233254A1 (en) 2021-03-11 2023-10-26 Janssen Pharmaceutica Nv Lorpucitinib for use in the treatment of jak mediated disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196078B2 (en) * 2002-09-04 2007-03-27 Schering Corpoartion Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
KR20050115252A (ko) * 2003-02-28 2005-12-07 데이진 화-마 가부시키가이샤 피라졸로[1,5-a]피리미딘 유도체
GB0305559D0 (en) 2003-03-11 2003-04-16 Teijin Ltd Compounds
US20070179161A1 (en) * 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
MXPA06002618A (es) * 2003-09-09 2006-06-05 Ono Pharmaceutical Co Antagonistas del factor de liberacion de corticotropina (crf) y compuestos heterobiciclicos.
EP1671962A1 (en) 2003-10-10 2006-06-21 Ono Pharmaceutical Co., Ltd. Novel fused heterocyclic compound and use thereof
JP2009502734A (ja) 2005-07-29 2009-01-29 アステラス製薬株式会社 Lck阻害剤としての縮合複素環
US20100029619A1 (en) 2006-08-04 2010-02-04 Takeda Pharmaceutical Company Limted Fused heterocyclic compound
CA2670083A1 (en) * 2006-11-20 2008-05-29 Alantos Pharmaceuticals Holding, Inc. Heterobicyclic metalloprotease inhibitors
AU2008223348A1 (en) 2007-03-07 2008-09-12 Alantos Pharmaceuticals Holding, Inc. Metalloprotease inhibitors containing a heterocyclic moiety

Similar Documents

Publication Publication Date Title
ES2280768T3 (es) Inhibidores de histona desacetilasa.
JP5432982B2 (ja) アポトーシスシグナル調節キナーゼ1阻害剤
US10632125B2 (en) MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
RU2357952C2 (ru) Новые эфиры гидроксамовых кислот и их фармацевтическое применение
JP6466433B2 (ja) ヒト免疫不全ウイルス複製の阻害剤
US7888374B2 (en) Inhibitors of c-jun N-terminal kinases
KR100985419B1 (ko) 2,3,6-트리치환된-4-피리미돈 유도체
JP2003507456A (ja) ケモカインレセプター活性のモジュレーターとして有用な置換ピペリジン化合物
RU2013114844A (ru) Новые соединения и композиции для ингибирования nampt
WO2010144647A1 (en) Nicotinamide compounds useful as kinase modulators
JP2015503529A5 (enExample)
JP2009537545A5 (enExample)
JP2005511531A (ja) 5’−アシルアミノ−1,1’−ビフェニル−4−カルボキサミド誘導体およびp38キナーゼ阻害剤としてのそれらの使用
WO2004018428A1 (en) Antibacterial benzoic acid derivatives
JP2013517273A5 (enExample)
KR19990022327A (ko) N-헤테로아릴-피리딘설폰아미드 유도체 및 이의 엔도텔린 길항 물질로서의 용도
JP2013505949A5 (enExample)
CA2570942A1 (en) Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicament
CN102884047A (zh) 2-吡啶酮化合物
EP2702043A1 (en) Inhibitors of inducible form of 6-phosphofructose-2-kinase
EP1406620A1 (en) Vinyl phenyl derivatives as glk activators
WO2014003124A1 (ja) 新規なアミド誘導体またはその塩
US20080280952A1 (en) Pyridine Derivatives as Connabinoid Receptor Modulators
JP2006124387A (ja) 新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法